Five9, Inc.
$2.91B- Market cap
- $2.33B
- Debt
- +$807.25M
- Cash
- −$232.08M
Capital structure 74% equity / 26% debt · EV / Revenue 2.53x · EV / EBITDA 21.28x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $2.33B · View financials
Snapshot Sep 8, 2026, 4:00 PM ET
Decision snapshot: FIVN stock price at discount vs ARCT $31.23 current versus $83.28 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ARCT's multiple
Implied fair value · at FIVN's multiple
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FIVN FY 2025 (ended Dec 31, 2025) · ARCT FY 2025 (ended Dec 31, 2025).
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Capital structure 74% equity / 26% debt · EV / Revenue 2.53x · EV / EBITDA 21.28x
Capital structure 90% equity / 10% debt · EV / Revenue 3.23x
FIVN carries the larger enterprise value at $2.91B against $265.34M; FIVN trades on the lower EV / Revenue multiple (2.53x vs 3.23x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Five9, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ARCTURUS THERAPEUTICS HOLDINGS INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.03x
0.24x
Net debt / EBITDA
Leverage against operating earnings
4.21x
2.72x
Cash and equivalents
Liquid reserves on the balance sheet
$232.08M
$230.91M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
RingCentral, Inc.
FIVN vs RNG
8X8 INC /DE/
FIVN vs EGHT
Zoom Communications, Inc.
FIVN vs ZM
PEGASYSTEMS INC
FIVN vs PEGA
VERINT SYSTEMS INC
FIVN vs VRNT
Moderna, Inc.
FIVN vs MRNA
BioNTech SE
FIVN vs BNTX
ALNYLAM PHARMACEUTICALS, INC.
FIVN vs ALNY
Sarepta Therapeutics, Inc.
FIVN vs SRPT
Intellia Therapeutics, Inc.
FIVN vs NTLA
$807.25M
$52.00M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.